CNS Pharmaceuticals Insider Trades
NASDAQ: CNSPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 2 · $44.00K
- Sales
- 0 · $0
- Shares bought / sold
- 9.10K / 0
- Net activity
- Net buying $44,002
CNS Pharmaceuticals insider activity
Over the last 12 months, CNS Pharmaceuticals insiders reported 3 transactions on SEC Form 4: 2 open-market purchases and 0 sales. Insiders bought $44,002 and sold $0 worth of stock, for net insider buying of $44,002. The most recent filing shows Levin Rami (CEO and President) reporting a transaction in 4,750 shares on Aug 14, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CNSP's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CNSP insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 14, 2026 | Levin RamiCEO and President | Option exercise | 4,750 | — | Form 4 |
| May 18, 2026 | Charles Faith L.Director | Buy | 7,100 | $34.00K | Form 4 |
| May 18, 2026 | Fisher MichalDirector | Buy | 2,000 | $10.00K | Form 4 |
| Feb 1, 2024 | Climaco John MChief Executive Officer | Buy | 166,666 | $50.00K | Form 4 |
| Feb 1, 2024 | Evans Carl AnthonyDirector | Buy | 33,333 | $10.00K | Form 4 |
| Feb 1, 2024 | Gumulka JerzyDirector | Buy | 33,333 | $10.00K | Form 4 |
| Feb 1, 2024 | Downs ChristopherChief Financial Officer | Buy | 66,666 | $20.00K | Form 4 |
| Aug 22, 2023 | Downs ChristopherChief Financial Officer | Buy | 27,000 | $34.18K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4